Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
388
datasets available to search
ShareScore release 0.9.0
Dataset results
388 results for “immune checkpoint inhibitors”
An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study
ClinicalTrials.gov study NCT05364086. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular C
ClinicalTrials.gov study NCT07310836. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
ClinicalTrials.gov study NCT05037825. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Re-challenge With Immune-Checkpoints Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients: a Retrospective Observational Study
ClinicalTrials.gov study NCT04069663. IPD Sharing: NO. Countries: 1. Publications: 0.
Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology
ClinicalTrials.gov study NCT03948724. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT03385486. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors
ClinicalTrials.gov study NCT06819735. IPD Sharing: NO. Countries: 1. Publications: 0.
Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer
ClinicalTrials.gov study NCT05059951. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective Study to Evaluate the Blood Kinetics of Immune Cells and Immunosuppressive Cytokines After Exposure to an Immunity Checkpoint Inhibitor (ICI): Study of the Impact of Chemotherapy
ClinicalTrials.gov study NCT04487457. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Discovery of Biomarkers Related to the Efficacy and Adverse Reactions of Immune Checkpoint Inhibitors Based on Metabolism-genomics
ClinicalTrials.gov study NCT04656119. IPD Sharing: NO. Countries: 1. Publications: 0.
SYSTEMATIC SYMPTOM ASSESSMENT IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
ClinicalTrials.gov study NCT04929353. IPD Sharing: NO. Countries: 1. Publications: 0.
SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT05387044. IPD Sharing: NO. Countries: 1. Publications: 0.
Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors.
ClinicalTrials.gov study NCT04595734. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Development of an EORTC Immune Checkpoint Inhibitor-specific Quality of Life Item List: Phase 1 & 2
ClinicalTrials.gov study NCT05554432. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Torque Teno Virus as a Biomarker for Predicting Treatment Response of Immune Checkpoint Inhibitor Therapy and Postoperative Outcome in NSCLC Patients
ClinicalTrials.gov study NCT06967532. IPD Sharing: YES. Countries: 1. Publications: 0.
CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC
ClinicalTrials.gov study NCT04495153. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
ClinicalTrials.gov study NCT06647134. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov study NCT04908566. IPD Sharing: YES. Countries: 1. Publications: 0.
Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer
ClinicalTrials.gov study NCT06818149. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression
ClinicalTrials.gov study NCT03305380. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.